// App-Quantinova.ai

: INTERPRETATION OF THE RESULTS OF ABO, RH-ANTIGENS AND ANTIBODIES DETERMINATION IN PATIENTS WITH HEMATOLOGICAL DISEASES

Researchers

Presenter

  • Irina Krobinets

Principal Investigators

  • Sergey Voloshin

  • Natalia Mineeva

  • Irina Bogdanova

  • Alexey Kuvshinov

  • Alexander Chechetkin

Medical Centers

  • Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia,

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Lympho proliferative disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • Myeloid neoplasms

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Polycythemia vera

  • Multiple Myeloma

  • Aplastic anemia

  • Myelofibrosis

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Anemia

Biomarkers

  • Breakpoint Cluster Region

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved